Drugs & Pharmaceuticals

Over the past several years, the medical community has learned, to its dismay, that we can experience a “twin-demic” of winter infectious diseases – simultaneous COVID-19 and flu outbreaks resulting in intense stresses on healthcare delivery.
In October 2022, I wrote one of the first articles about xylazine (aka "Tranq"), a drug that was being used (especially in Philadelphia) to cut fentanyl, as if w
In the mid-1990s, an evil new practice – the use of drugs to incapacitate women so that they could not resist sexual assaults – became a serious threat to millions of women.
Anyone who has had the sick, masochistic obsession pleasure of reading my stuff over the years knows quite well that I am not a fan of dietary supplements. So much so that in 2015 New York Attorney General Eric T.
Once upon a time in a land far, far away there was a little antibiotic biotech.
A new study released earlier this year adds more evidence to the mountains of evidence that policymakers trying to solve the overdose crisis have been aiming at the wrong target.
Last week, Merck filed suit against the US Department of Health and Human Services to prevent them from implementing drug pricing provision of the Inflation Reduction Act.
Enantiomerism – the property of asymmetric molecules that look "the same" but are actually mirror images of each other – is one of the many topics, perhaps the most egregious, that drive organic chemistry students bats###t crazy.
As many of you know, I spent many working days in Europe during my career and I still live there several months a year.  In fact, I’m currently in a rather cool, wet Europe.
During my years as an FDA official, I learned that there is a fundamental fact of life that underlies all drug testing and regulatory review: The data are seldom as complete and unequivocal as you might like.
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!



Popular articles